康方生物涨超4% 依沃西HARMONi研究成果以LBA形式入选Plenary oral

智通财经
Aug 14, 2025

康方生物(09926)涨超4%,截至发稿,涨4.44%,报164.6港元,成交额14.04亿港元。消息面上,康方生物今日公布,2025年世界肺癌大会(WCLC)将于9月6日-9日在西班牙巴塞罗那举行。会议期间,康方生物海外合作伙伴Summit Therapeutics,将重磅发布公司全球首创PD-1/VEGF双特异性抗体新药依沃西首个国际多中心注册性Ⅲ期临床HARMONi研究的结果,该研究结果作为...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10